SHA:600285 Revenue

Henan Lingrui Pharmaceutical had revenue of 1.02B CNY in the quarter ending March 31, 2025, with 12.29% growth. This brings the company's revenue in the last twelve months to 3.61B, up 5.26% year-over-year. In the year 2024, Henan Lingrui Pharmaceutical had annual revenue of 3.50B with 5.72% growth.

Revenue (ttm)

3.61B

Revenue Growth

+5.26%

P/S Ratio

3.56

Revenue / Employee

1.43M

Employees

2,530

Market Cap

12.87B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.50B	189.36M	5.72%
Dec 31, 2023	3.31B	309.61M	10.31%
Dec 31, 2022	3.00B	308.35M	11.45%
Dec 31, 2021	2.69B	361.93M	15.52%
Dec 31, 2020	2.33B	174.53M	8.09%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings